Home   Package List   Routine Alphabetical List   Global Alphabetical List   FileMan Files List   FileMan Sub-Files List   Package Component Lists   Package-Namespace Mapping  
Routine: DVBCWSD5

DVBCWSD5.m

Go to the documentation of this file.
  1. DVBCWSD5 ;ALB/RLC SKIN DISEASES (Other Than Scars) WKS TEXT - 1 ; 11/20/02 4:43pm
  1. ;;2.7;AMIE;**81**;Apr 10, 1995
  1. ;
  1. ;
  1. TXT ;
  1. ;;A. Review of Medical Records:
  1. ;;
  1. ;;
  1. ;;
  1. ;;B. Medical History (Subjective Complaints):
  1. ;;
  1. ;; 1. Describe onset and course of disease, whether it is
  1. ;; intermittent or constant, and whether it is progressive.
  1. ;;
  1. ;;
  1. ;; 2. Describe current treatment. Specify the medication(s)
  1. ;; used and dosage. State whether any is a corticosteroid
  1. ;; or other immunosuppresive drug. State whether medications
  1. ;; used are systemic or topical. Describe whether intensive
  1. ;; light therapy, UVB, PUVA, or electron beam therapy are used.
  1. ;;
  1. ;;
  1. ;; 3. For EACH treatment, report the frequency of use and duration
  1. ;; of treatment during the past 12-month period.
  1. ;;
  1. ;;
  1. ;; 4. Describe any side effects of treatment.
  1. ;;
  1. ;;
  1. ;; 5. Describe local (skin) symptoms and any systemic symptoms,
  1. ;; such as fever or weight loss.
  1. ;;
  1. ;;
  1. ;; 6. For malignant neoplasms of skin, additionally describe
  1. ;; all treatment, including date and type of last treatment.
  1. ;;
  1. ;;
  1. ;; 7. For benign neoplasms of skin, additionally describe any
  1. ;; impairment of function.
  1. ;;
  1. ;;
  1. ;; 8. For urticaria, primary cutaneous vasculitis, and
  1. ;; erythema multiforme, additionally describe the number of
  1. ;; episodes during the past 12-month period, whether the
  1. ;; episodes are debilitating, how they are treated, and
  1. ;; whether they respond to treatment.
  1. ;;
  1. ;;C. Physical Examination (Objective Findings):
  1. ;;
  1. ;; 1. For dermatitis, eczema, leishmaniasis, lupus, dermatophytosis,
  1. ;; bullous disorders, psoriasis, infections of the skin,
  1. ;; cutaneous manifestations of collagen vascular diseases, and
  1. ;; papulosquamous disorders, report extent of disease. Specify
  1. ;; if any exposed areas (head, face, neck and hands) are
  1. ;; affected. Provide the percent affected of exposed areas.
  1. ;; Provide the percent affected of the entire body.
  1. ;;
  1. ;;
  1. ;; 2. If there is scarring or disfigurement, follow the "Scars"
  1. ;; worksheet in addition to this one.
  1. ;;
  1. ;;
  1. ;; 3. For acne or chloracne, describe whether the acne is
  1. ;; superficial (with comedones, papules, pustules, superficial
  1. ;; cysts) or deep (with deep inflamed nodules and pus-filled
  1. ;; cysts), which areas of the body are affected, and,
  1. ;; specifically, the PERCENT OF FACE AND NECK affected.
  1. ;;
  1. ;;
  1. ;; 4. For scarring alopecia, describe the PERCENT OF THE SCALP
  1. ;; that is affected.
  1. ;;
  1. ;;
  1. ;; 5. For alopecia areata, describe whether there is loss of all
  1. ;; body hair or whether loss of hair is limited to the scalp
  1. ;; and face.
  1. ;;
  1. ;;
  1. ;; 6. For hyperhidrosis, state whether veteran is able to handle
  1. ;; paper or tools after therapy, or is unable to handle paper
  1. ;; or tools because of moisture and is unresponsive to therapy.
  1. ;;
  1. ;;D. Diagnostic and Clinical Tests:
  1. ;;
  1. ;; 1. Biopsy, scrapings if indicated.
  1. ;; 2. Include results of all diagnostic and clinical tests conducted
  1. ;; in the examination report.
  1. ;; 3. With disfigurement or disfiguring scar of head, face, or
  1. ;; neck, submit COLOR PHOTOGRAPHS.
  1. ;; 4. Test for hypoproteinemia if examining for exfoliative
  1. ;; dermatitis (erythroderma).
  1. ;;
  1. ;;E. Diagnosis:
  1. ;;
  1. ;;
  1. ;;Signature: Date:
  1. ;;END